Laddar...
Strategy to targeting the immune resistance and novel therapy in colorectal cancer
Assessing the CRC subtypes that can predict the outcome of colorectal cancer (CRC) in patients with immunogenicity seems to be a promising strategy to develop new drugs that target the antitumoral immune response. In particular, the disinhibition of the antitumoral T‐cell response by immune checkpoi...
Sparad:
| I publikationen: | Cancer Med |
|---|---|
| Huvudupphovsmän: | , , , , , , , , |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
John Wiley and Sons Inc.
2018
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5943429/ https://ncbi.nlm.nih.gov/pubmed/29658188 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cam4.1386 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|